Site icon SD News Wire

Neuropeptide Y Receptor Market Statistics, Segment, Trends and Forecast to 2032

Neuropeptide Y Receptor Market

Neuropeptide Y Receptor Market

Neuropeptide Y Receptor Market is a neurotransmitter that is involved in the regulation of appetite, stress response, and anxiety. Neuropeptide Y receptor (NPYR) is a protein that binds with NPY to trigger various physiological responses. The market refers to the global market for drugs that target NPYR for the treatment of various diseases and disorders.

Market Overview: The global neuropeptide Y receptor market was valued at USD 1.45 billion in 2021 and is expected to reach USD 2.24 billion by 2028, growing at a CAGR of 6.2% during the forecast period (2021-2028). The market growth is attributed to the increasing prevalence of obesity and related disorders, rising demand for effective therapeutics for anxiety and depression, and the growing awareness of mental health disorders.

Visit Report Page for More Details: https://stringentdatalytics.com/reports/neuropeptide-y-receptor-market/476/

The market is expected to witness significant growth during the forecast period, driven by the increasing prevalence of obesity and related disorders, rising demand for effective therapeutics for anxiety and depression, and the growing awareness of mental health disorders.

The market is highly competitive, with several key players operating in the market. Further, the market is expected to witness significant growth opportunities in the Asia Pacific region due to the increasing healthcare expenditure and growing awareness of mental health disorders.

Market Segmentations:

Global Neuropeptide Y Receptor Market: By Company
• Gila Therapeutics
• Novo Nordisk
• XL-protein
• Lilly Eli
• Novartis
• Pfizer
• Merck & Co
• Mannkind
• Gilead Sciences
• Genentech

Global Neuropeptide Y Receptor: By Type
• Food Grade
• Pharmaceutical Grade

Global Neuropeptide Y Receptor: By Application
• Medicine
• Food Additives
• Others

Global Neuropeptide Y Receptor Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Neuropeptide Y Receptor market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.

 

Click Here, To Get Free Sample Report: https://stringentdatalytics.com/sample-request/neuropeptide-y-receptor-market/476/

Objectives of Neuropeptide Y Receptor Market Study:

About US:

Stringent Datalytics offers both custom and syndicated market research reports. Custom market research reports are tailored to a specific client’s needs and requirements. These reports provide unique insights into a particular industry or market segment and can help businesses make informed decisions about their strategies and operations.

Syndicated market research reports, on the other hand, are pre-existing reports that are available for purchase by multiple clients. These reports are often produced on a regular basis, such as annually or quarterly, and cover a broad range of industries and market segments. Syndicated reports provide clients with insights into industry trends, market sizes, and competitive landscapes. By offering both custom and syndicated reports, Stringent Datalytics can provide clients with a range of market research solutions that can be customized to their specific needs.

Contact US:

Stringent Datalytics

Contact No – 91-9763384149

Email Id –  sales@stringentdatalytics.com

Exit mobile version